Spruce Biosciences to enact 1-for-75 reverse stock split
Source: SeekingAlpha
2025-07-24 16:15:20 ET
More on Spruce Biosciences
- Spruce Biosciences gets conditional approval to resume trading on Nasdaq Capital Market
- Seeking Alpha’s Quant Rating on Spruce Biosciences
- Historical earnings data for Spruce Biosciences
- Financial information for Spruce Biosciences
Read the full article on Seeking Alpha
For further details see:
Spruce Biosciences to enact 1-for-75 reverse stock split
Spruce Biosciences Inc.
NASDAQ: SPRB
SPRB Trading
8.16% G/L:
$67.60 Last:
75,356 Volume:
$71.50 Open:
SPRB Latest News
March 09, 2026 07:05:00 am
Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates
SPRB Stock Data
$90,018,117
658,278
2.53%
34
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
